However, this approach is not routine first-line treatment in UK practice, is considered off-label, and requires good patient adherence and clinical follow-up
References: Chang, Chung-Hsun et al
How KPV Compares to Standard IBD Therapies When managing inflammatory bowel disease, patients are often faced with tough choices
This is not an issue with an injection (since IM/IV bypasses the gut), but if a patient is also taking oral supplements, they should separate them from tetracycline dosing
They are commercial arguments
Unlike regular pharmacies that sell pre-manufactured drugs, compounding pharmacies can put prescribed drugs into custom topical treatments, injectables, flavored liquids, and more at specified doses